Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) EBIT Margin (2016 - 2025)

Historic EBIT Margin for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to 120.19%.

  • MediWound's EBIT Margin fell 35200.0% to 120.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 112.59%, marking a year-over-year decrease of 254000.0%. This contributed to the annual value of 95.94% for FY2024, which is 141100.0% down from last year.
  • As of Q3 2025, MediWound's EBIT Margin stood at 120.19%, which was down 35200.0% from 100.14% recorded in Q2 2025.
  • MediWound's 5-year EBIT Margin high stood at 18.27% for Q4 2022, and its period low was 132.11% during Q1 2025.
  • Its 5-year average for EBIT Margin is 76.74%, with a median of 75.22% in 2024.
  • In the last 5 years, MediWound's EBIT Margin soared by 824400bps in 2022 and then tumbled by -912200bps in 2023.
  • Quarter analysis of 5 years shows MediWound's EBIT Margin stood at 64.17% in 2021, then surged by 128bps to 18.27% in 2022, then plummeted by -499bps to 72.95% in 2023, then crashed by -43bps to 104.47% in 2024, then dropped by -15bps to 120.19% in 2025.
  • Its EBIT Margin was 120.19% in Q3 2025, compared to 100.14% in Q2 2025 and 132.11% in Q1 2025.